I am a
Home I AM A Search Login

Papers of the Week

2022 May

Pain Physician



Impact Of COVID-19 Pandemic and Updated Utilization Patterns of Sacroiliac Joint Injections from 2000 to 2020 in The Fee-For-Service (FFS) Medicare Population.


Manchikanti L, Simopoulos TT, Pampati V, Manchikanti MV, Kosanovic R, Abdi S, Sanapati MR, Koyyalagunta D, Knezevic N N, Beall DP, Soin A, Kaye AD, Abd-Elsayed A, Hirsch JA
Pain Physician. 2022 May; 25(3):239-250.
PMID: 35652764.


Among the multiple causes of low back and lower extremity pain, sacroiliac joint pain has shown to be prevalent in 10% to 25% of patients with persistent axial low back pain without disc herniation, discogenic pain, or radiculitis. Over the years, multiple Current Procedural Terminology (CPT) codes have evolved with the inclusion of intraarticular injections, nerve blocks, and radiofrequency neurotomy, in addition to percutaneous sacroiliac joint fusions. Previous assessments of utilization patterns of sacroiliac joint interventions only included sacroiliac joint intraarticular injections, since the data was not available prior to the introduction of new codes. A recent assessment revealed an increase of 11.3%, and an annual increase of 1.2% per 100,000 Medicare population from 2009 to 2018, showing a decline in growth patterns. During the past 2 years, the COVID-19 pandemic has also had significant effects on the utilization patterns of sacroiliac joint interventions.